Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. (Q46558371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

neuromuscular junction

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

7

Hugh J Willison

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

5

John A Goodfellow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

4

Peter D Humphreys

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

6

Jaap J Plomp

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Ian Morrison

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Graham M O'Hanlon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

177-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15968629%20AND%20SRC:MED&resulttype=core&format=json

The neuromuscular junction of the mouse after black widow spider venom

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Tetramerisation of α-latrotoxin by divalent cations is responsible for toxin-induced non-vesicular release and contributes to the Ca2+-dependent vesicular exocytosis from synaptosomes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Glial cells and neurotransmission: an inclusive view of synaptic function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Glial cells as active partners in synaptic functions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Glial modulation of synaptic transmission at the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Anti-GT1a IgG in Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Factors defining target specificity in antibody-mediated neuropathy: density-dependent binding of anti-GD1a polyclonal IgG from a neurological patient

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Autoantibodies to ion channels at the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Botulism: the agent, mode of action of the botulinum neurotoxins, forms of acquisition, treatment and prevention

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Diseases of the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Synapse-glia interactions at the mammalian neuromuscular junction.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Dysfunction at the motor end-plate and axon membrane in Guillain-Barré syndrome: a single-fiber EMG study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Fine specificity of anti-GQ1b IgG and clinical features

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Cell density regulates crypticity of GM3 ganglioside on human glioma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

The immunopathogenesis of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Peripheral neuropathies and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021

Presynaptic neuromuscular transmission block in Guillain-Barré syndrome associated with anti-GQ1b antibodies

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20228

7 January 2021